398 related articles for article (PubMed ID: 25982245)
1. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
2. Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.
Opazo-Ríos L; Plaza A; Sánchez Matus Y; Bernal S; Lopez-Sanz L; Jimenez-Castilla L; Carpio D; Droguett A; Mezzano S; Egido J; Gomez-Guerrero C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545818
[TBL] [Abstract][Full Text] [Related]
3. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide.
Davé SH; Tilstra JS; Matsuoka K; Li F; Karrasch T; Uno JK; Sepulveda AR; Jobin C; Baldwin AS; Robbins PD; Plevy SE
J Immunol; 2007 Dec; 179(11):7852-9. PubMed ID: 18025231
[TBL] [Abstract][Full Text] [Related]
5. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
Vandekerckhove L; Vermeulen Z; Liu ZZ; Boimvaser S; Patzak A; Segers VF; De Keulenaer GW
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E495-504. PubMed ID: 26786778
[TBL] [Abstract][Full Text] [Related]
8. Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.
Lazaro I; Oguiza A; Recio C; Mallavia B; Madrigal-Matute J; Blanco J; Egido J; Martin-Ventura JL; Gomez-Guerrero C
Diabetes; 2015 Oct; 64(10):3600-13. PubMed ID: 26116697
[TBL] [Abstract][Full Text] [Related]
9. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
[TBL] [Abstract][Full Text] [Related]
10. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
[TBL] [Abstract][Full Text] [Related]
11. Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Pugliese G
Diabetologia; 2015 Apr; 58(4):845-53. PubMed ID: 25471794
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice.
Fang Q; Wang J; Wang L; Zhang Y; Yin H; Li Y; Tong C; Liang G; Zheng C
Toxicol Appl Pharmacol; 2015 Oct; 288(2):179-91. PubMed ID: 26206226
[TBL] [Abstract][Full Text] [Related]
13. D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.
Reay DP; Bastacky SI; Wack KE; Stolz DB; Robbins PD; Clemens PR
Mol Med; 2015 May; 21(1):442-52. PubMed ID: 26018805
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.
Gareus R; Kotsaki E; Xanthoulea S; van der Made I; Gijbels MJ; Kardakaris R; Polykratis A; Kollias G; de Winther MP; Pasparakis M
Cell Metab; 2008 Nov; 8(5):372-83. PubMed ID: 19046569
[TBL] [Abstract][Full Text] [Related]
15. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
Dai S; Hirayama T; Abbas S; Abu-Amer Y
J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
[TBL] [Abstract][Full Text] [Related]
16. A novel salviadione derivative, compound 15a, attenuates diabetes-induced renal injury by inhibiting NF-κB-mediated inflammatory responses.
Li L; Ding C; Zou C; Xiong Z; Zhu W; Qian J; Xu M; Zhang A; Liang G
Toxicol Appl Pharmacol; 2020 Dec; 409():115322. PubMed ID: 33171189
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.
May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S
Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790
[TBL] [Abstract][Full Text] [Related]
18. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.
Baima ET; Guzova JA; Mathialagan S; Nagiec EE; Hardy MM; Song LR; Bonar SL; Weinberg RA; Selness SR; Woodard SS; Chrencik J; Hood WF; Schindler JF; Kishore N; Mbalaviele G
J Biol Chem; 2010 Apr; 285(18):13498-506. PubMed ID: 20167598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
